Download presentation
Presentation is loading. Please wait.
Published byTheodore Potter Modified over 6 years ago
1
Surgical treatment of hepatic and pulmonary metastases from colon cancer
James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen, MD, Claude Deschamps, MD, Victor F Trastek, MD, Peter C Pairolero, MD The Annals of Thoracic Surgery Volume 71, Issue 3, Pages (March 2001) DOI: /S (00)
2
Fig 1 Probability of survival (death from any cause) in 58 patients who underwent resection of hepatic and pulmonary metastasis from colon cancer. Zero time on abscissa represents date of first lung resection. The Annals of Thoracic Surgery , DOI: ( /S (00) )
3
Fig 2 Probability of survival (death from any cause) in 11 patients with normal preoperative carcinoembryonic antigen (CEA) levels as compared to 16 patients with abnormal (> 5 ng/mL) carcinoembryonic antigen levels. Zero time on abscissa represents date of first lung resection. The Annals of Thoracic Surgery , DOI: ( /S (00) )
4
Fig 3 Probability of survival (death from any cause) in 13 patients who had adjuvant therapy after pulmonary resection as compared to 45 patients who had none. Zero time on abscissa represents date of first lung resection. (Tx = therapy). The Annals of Thoracic Surgery , DOI: ( /S (00) )
5
Fig 4 Probability of survival (death from any cause) in 16 patients who underwent additional lung resections for recurrent disease. Zero time on abscissa represents date of second lung resection. The Annals of Thoracic Surgery , DOI: ( /S (00) )
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.